nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cetuximab combined with chemotherapy in non-small cell lung cancer
|
Tsao, Anne S. |
|
2010 |
7 |
1 |
p. 17-22 6 p. |
artikel |
2 |
Emerging experience with histone deacetylase inhibitors
|
Zic, John A. |
|
2010 |
7 |
1 |
p. 37-38 2 p. |
artikel |
3 |
Innovations, then and now
|
Schwartzberg, Lee S. |
|
2010 |
7 |
1 |
p. 2- 1 p. |
artikel |
4 |
Measures of risk
|
Streiner, David L. |
|
2010 |
7 |
1 |
p. 39-41 3 p. |
artikel |
5 |
Overview of hypersensitivity to cancer therapies
|
O'Neil, Bert H. |
|
2010 |
7 |
1 |
p. 11-16 6 p. |
artikel |
6 |
Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors
|
Wood, Laura S. |
|
2010 |
7 |
1 |
p. 23-29 7 p. |
artikel |
7 |
Radioimmunotherapy: a promising treatment strategy for follicular lymphoma
|
Abraham, Jame |
|
2010 |
7 |
1 |
p. 7-10 4 p. |
artikel |
8 |
Vorinostat in combination therapy for cutaneous Tcell lymphoma: a first year of clinical experience at a single center
|
Geskin, Larisa J. |
|
2010 |
7 |
1 |
p. 31-36 6 p. |
artikel |
9 |
Year-end cliffhanger: CMS fee cut
|
Young, Patrick |
|
2010 |
7 |
1 |
p. 48- 1 p. |
artikel |